Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study

Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Thomas Nyström, Irene Santos-Pardo, Fredric Hedberg, Johan Wardell, Nils Witt, Yang Cao, Leif Bojö, Bo Nilsson, Johan Jendle
Formáid:	Alt
Teanga:	English
Foilsithe / Cruthaithe:	Frontiers Media S.A. 2018-02-01
Sraith:	Frontiers in Endocrinology
Ábhair:	longitudinal functional reserve index liraglutide subclinical heart failure tissue Doppler echocardiography type 2 diabetes
Rochtain ar líne:	http://journal.frontiersin.org/article/10.3389/fendo.2018.00050/full

Míreanna comhchosúla

Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study
de réir: Thomas Nyström, et al.
Foilsithe / Cruthaithe: (2017-11-01)

Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride
de réir: J. Jendle, et al.
Foilsithe / Cruthaithe: (2021-12-01)

Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial
de réir: Nikolai N. Scherbak, et al.
Foilsithe / Cruthaithe: (2023-09-01)

Liraglutide overdose: A case report and an updated review
de réir: Sharafaldeen Bin Nafisah, et al.
Foilsithe / Cruthaithe: (2020-01-01)

Metformin exerts synergistic anti-proliferative effects with Liraglutide in human umbilical vein endothelial cells (HUVECs)
de réir: Amir Shadboorestan, et al.
Foilsithe / Cruthaithe: (2022-04-01)

Liraglutide Drug Loading with Double Layered Hydroxide- Synthesis and Characterization
de réir: Sevan Adeeb Doshan, et al.
Foilsithe / Cruthaithe: (2020-06-01)

Liraglutide and Exercise: A Possible Treatment for Obesity?
de réir: Ana Paula Azevêdo Macêdo, et al.
Foilsithe / Cruthaithe: (2022-08-01)

Effect of metformin versus metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome
de réir: Chuan Xing, et al.
Foilsithe / Cruthaithe: (2022-08-01)

Hippocampal Ganglioside Composition is Altered by Metformin and Liraglutide Treatment in A High-Fat High-Sugar Diet Rat Model
de réir: Marin Kuharić, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Efficacy and safety of liraglutide in Indian adolescents with obesity
de réir: I. S. Kochar, et al.
Foilsithe / Cruthaithe: (2019-06-01)

Ejaculate quality indicators of men with asthenozoospermia and asthenoteratozoospermia by treatment of obesity with liraglutide
de réir: D. N. Bobkov, et al.
Foilsithe / Cruthaithe: (2021-10-01)

Therapeutic efficacy of liraglutide versus metformin in modulating the gut microbiota for treating type 2 diabetes mellitus complicated with nonalcoholic fatty liver disease
de réir: Xing Ying, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Liraglutide abrogates nephrotoxic effects of chemotherapies
de réir: Cong Xu, et al.
Foilsithe / Cruthaithe: (2023-03-01)

Role of liraglutide in Alzheimer’s disease pathology
de réir: Maria Vargas-Soria, et al.
Foilsithe / Cruthaithe: (2021-06-01)

Long-term efficacy of liraglutide in Indian patients with Type 2 diabetes in a real-world setting
de réir: Parjeet Kaur, et al.
Foilsithe / Cruthaithe: (2016-01-01)

Comparison of Postprandial Insulin Levels in Withania Coagulans and Liraglutide Treated Diabetic Rats
de réir: Abdul Samad, Shazia Ali, Noman Sadiq
Foilsithe / Cruthaithe: (2018-12-01)

Comparison of the effects of liraglutide and sibutramine in obese patients
de réir: G. A. Matveev, et al.
Foilsithe / Cruthaithe: (2021-07-01)

Continuation of Liraglutide during Fasting is not Associated with Hypoglycaemia
de réir: Rosalie Koot, et al.
Foilsithe / Cruthaithe: (2017-10-01)

Clinical Impact of Liraglutide as a Treatment of Obesity
de réir: Alruwaili H, et al.
Foilsithe / Cruthaithe: (2021-03-01)

Effects of liraglutide and empagliflozin added to insulin therapy in patients with type 2 diabetes: A randomized controlled study
de réir: Hirotatsu Nakaguchi, et al.
Foilsithe / Cruthaithe: (2020-11-01)

Histopathological Study of Liraglutide on Renal Deterioration Progression Induced by Doxorubicin
de réir: Hayder Hussein Luaibi, et al.
Foilsithe / Cruthaithe: (2019-12-01)

The effects of liraglutide on the characteristics of blood parameters and testicular tissue induced diabetes and obesity in mice
de réir: Saied Mohammadzadeh, et al.
Foilsithe / Cruthaithe: (2024-08-01)

Low dose liraglutide in Indian patients with type 2 diabetes in the real world setting
de réir: Debmalya Sanyal, et al.
Foilsithe / Cruthaithe: (2013-01-01)

Obezitenin Medikal Tedavisinde Liraglutide Etkinliğinin Araştırılması
de réir: Murat Kose, et al.
Foilsithe / Cruthaithe: (2023-09-01)

The Discovery and Development of Liraglutide and Semaglutide
de réir: Lotte Bjerre Knudsen, et al.
Foilsithe / Cruthaithe: (2019-04-01)

First GLP-1 analog liraglutide: the result of clinical trails on efficacy
de réir: Alexander Sergeevich Ametov, et al.
Foilsithe / Cruthaithe: (2011-12-01)

Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetes
de réir: Damien Denimal, et al.
Foilsithe / Cruthaithe: (2023-05-01)

Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction
de réir: Qi Q, et al.
Foilsithe / Cruthaithe: (2017-07-01)

Comparative cardiovascular and renal outcomes of Liraglutide versus Dulaglutide in Asian type 2 diabetes patients
de réir: Jhih-Wei Dai, et al.
Foilsithe / Cruthaithe: (2024-11-01)

Liraglutide; A New Hope for Obese Diabetics
de réir: Ajeet Kumar, et al.
Foilsithe / Cruthaithe: (2020-12-01)

Complex vasoactivity of liraglutide. Contribution of three gasotransmitters
de réir: Eszter Sélley, et al.
Foilsithe / Cruthaithe: (2015-05-01)

Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial ( 2023;47:668-81)
de réir: Nikolai N. Scherbak, et al.
Foilsithe / Cruthaithe: (2023-11-01)

The Efficacy and Safety of Liraglutide 3.0 mg for Weight Management in Obese Non-Diabetic Saudi Outpatients
de réir: Albaker W, et al.
Foilsithe / Cruthaithe: (2021-11-01)

Liraglutide for Weight Management in the Real World: Significant Weight Loss Even if the Maximal Daily Dose Is Not Achieved
de réir: Liesbet Trenson, et al.
Foilsithe / Cruthaithe: (2021-11-01)

Combination therapies in the management of type 2 diabetes: the use of insulin degludec/liraglutide
de réir: Minze MG, et al.
Foilsithe / Cruthaithe: (2016-03-01)

Liraglutide in adolescents with simple obesity and gastrointestinal comorbidities: treatment experience
de réir: A. V. Vitebskaya, et al.
Foilsithe / Cruthaithe: (2023-07-01)

Molecular mechanisms of semaglutide and liraglutide as a therapeutic option for obesity
de réir: Rafael Tamayo-Trujillo, et al.
Foilsithe / Cruthaithe: (2024-04-01)

Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetes
de réir: Campbell RK, et al.
Foilsithe / Cruthaithe: (2010-07-01)

The Effects of Liraglutide on In Vitro Fertilization in Mice Following Experimental Diabetes
de réir: Rafieh Khalily, et al.
Foilsithe / Cruthaithe: (2020-03-01)

Low dose of liraglutide combined with metformin leads to a significant weight loss in Chinese Han women with polycystic ovary syndrome: a retrospective study
de réir: Xuefeng Long, et al.
Foilsithe / Cruthaithe: (2023-12-01)